VCU Health and Massey are monitoring the approach of winter weather. 

Learn more
View alerts

Leading the nation’s cancer advancements through research

Massey's nationally recognized research programs comprises nearly 150 research members discovering and developing a future without cancer.

Explore our programs

One of the Nation’s leading cancer research centers

VCU Massey Comprehensive Cancer Center is proud to be your local National Cancer institute (NCI)-designated Comprehensive Cancer Center. As one of just two centers in Virginia with this distinction, Massey is at the forefront of the nation’s cancer research efforts. Massey has been designated by the NCI since 1975 and received comprehensive status in 2023.

Learn more about Massey's quest for comprehensive designation

Preeminent research programs

Massey research members conduct cutting-edge research and lead collaborative initiatives through one of three scientific research programs.

Cancer Biology

Unraveling the causes of the growth and spread of cancer and identifying key interactions between tumors and their microenvironment

Developmental Therapeutics

Discovering, developing and evaluating novel, small molecules and biologics through clinical trials

Cancer Prevention & Control

Advancing cancer risk identification and mitigation as well as improved approaches to survivorship

Research events

Research events

Massey sponsors a range of research events for trainees and researchers.

Intramural funding

Intramural funding

Explore intramural funding opportunities for novel cancer-related research concepts.

Shared resources

Shared resources

Shared resources support the extensive cancer research portfolio of Massey scientists.

Related news

View all news

Research

New study aims to reduce side effects for kids on chemotherapy

Mar 19, 2025

Research completed a group of researchers from VCU Massey Comprehensive Cancer Center and the Children’s Hospital of Richmond (CHoR) about whether providers could safely give less fluid without impacting the management of the chemo side effects was recently published in Pediatric Blood & Cancer...

Research

Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation

Mar 18, 2025

A team of scientists at VCU Massey Comprehensive Cancer Center have discovered a new combination therapy —sotorasib and an experimental drug called FGTI-2734—that overcomes drug resistance and makes targeted treatment more effective in lung tumors harboring a specific mutation. ...